Octagon Capital Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-39,680	Closed	-$1.42M	–	38
2024 Q4	$1.42M	Hold	39,680	–	–	0.23%	30
2024 Q3	$1.87M	Hold	39,680	–	–	0.29%	34
2024 Q2	$1.99M	Sell	39,680 -320	-0.8%	-$16.1K	0.31%	36
2024 Q1	$4.48M	Buy	+40,000	New	+$4.48M	0.54%	38